HCM
VCYT icon

Highbridge Capital Management’s Veracyte VCYT Stock Holding History

Highbridge Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,817
Closed -$132K – 1795
2017
Q2 		$132K Sell
15,817
-9,080
-36% -$74.1K ﹤0.01% 1161
2017
Q1 		$229K Buy
24,897
+10,337
+71% +$84.6K ﹤0.01% 1275
2016
Q4 		$112K Buy
+14,560
New +$109K ﹤0.01% 1192

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Highbridge Capital Management's VCYT Position: Q3 2017 in Review

Highbridge Capital Management sold out of Veracyte (VCYT) in Q3 2017, closing a stake of 15,817 shares — an estimated $132K sold.

Highbridge Capital Management first reported a position in VCYT in Q4 2016 and held it in 3 quarters. The position peaked at $229K in Q1 2017. 87 funds tracked by Wall St. Rank hold VCYT as of Q3 2017.

  • Highbridge Capital Management reported no remaining Veracyte position as of Q3 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 15,817 Veracyte shares in Q3 2017, an estimated $132K.
  • Highbridge Capital Management first reported a position in Veracyte in Q4 2016 and held it in 3 quarters.
  • Highbridge Capital Management's Veracyte position peaked at $229K in Q1 2017.
  • 87 funds tracked by Wall St. Rank held Veracyte as of Q3 2017.

Based on Highbridge Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.